Company: GlaxoSmithKline (Ireland) Ltd. Legal category: HT. Sport permitted. Active ingredient: Lapatinib ditosylate monohydrate, eq. to 250mg lapatinib. Description: Oval, biconvex, yellow film-coated tablets, with GS XJG debossed on one side. Presentation: 70, price available on request. Indications: In combination with capecitabine for the treatment of advanced or metastatic breast cancer in patients with tumours [...]
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as hydrochloride) 37.5mg, 75mg. Description: Respectively pale red-brown oblong tablet, coded 3 and pale red-brown oblong scored tablet, coded 7 on each half. Presentation: 37.5mg-56, €18.07; 75mg-56, €30.13. Indications: Treatment of depressive illness including depression accompanied by anxiety. Prevention of relapses of the [...]
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as hydrochloride) 37.5mg, 75mg, 150mg. Description: Respectively, light grey, flesh-coloured and orange prolonged-release hard capsules containing white to off-white pellets. Presentation: 37.5mg-7, €3.04; 75mg-28, €17.47; 150mg-28, €29.45. Indications: Major depressive episodes. Pharmacology: Venlafaxine is a structurally novel antidepressant which is chemically unrelated to [...]
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Warfarin (sodium) 1mg, 3mg. 5mg. Description: Brown, blue, pink flat, capsule shaped, scored tablets with WARFARIN on top of TARO engraved on one side and 1, 3, 5 on the other side, respectively. The score line is only to facilitate breaking for ease [...]
AstraZeneca Pharmaceuticals wish to inform you of a change in packaging for Symbicort Turbohaler (formoterol/budesonide). The new packs are for all strengths of Symbicort (100/6, 200/6, 400/12). Features of the new pack include new font, design and colours that will make differentiation easier between pack strengths. There is also a new readability-tested patient information leaflet. [...]
Boehringer Inghelheim Ireland Ltd wishes to advise you that Alupent Expectorant Mixture will be discontinued on 31st January 2009. Alupent Syrup and Bisolvon are unaffected by this discontinuation and will remain available. These two products may be used at the discretion of the prescribing physician as a suitable therapeutic alternative to Alupent Expectorant Mixture. Boehringer [...]
Grunenthal Pharma Ltd regrets to announce the discontinuation of Clarosip 125mg, 187.5mg and 250mg clarithromycin granules for oral suspension from 24th November 2008. They regret the inconvenience that this may cause and refer physicians to suitable alternatives that remain available. Any stock remaining in circulation should be utilised until it is exhausted or expired. Should [...]
Servier Laboratories wish to announce the withdrawal of Diamicron 80mg. Stock of Diamicron 80mg will be completely withdrawn by December 2008. Prescribers are advised to prescribe Diamicron MR as an alternative to Diamicron 80mg from 30th November 2008. Diamicron MR is bio-equivalent to Diamicron 80mg and can be substituted on a tablet for tablet basis. [...]
In agreement with the Irish Medicines Board, Shire plc wishes to advise you of the discontinuation of Dynepo. Dynepo is an erythropoiesis-stimulating agent (ESA) indicted for the treatment of symptomatic anaemia associated with chronic renal failure in adult patients.Dynepo will be discontinued from 31st January 2009. This notification is not a product recall or result [...]
Roche Products (Ireland) Ltd wishes to inform you of the discontinuation of three of its products, NeoRecormon 10,000 IU lyophilisate and solvent for solution for injection in cartridge (pack size of 1), NeoRecormon 20,000 IU lyophilisate and solvent for solution for injection in cartridge (pack size of 1), NeoRecormon 1,000 IU solution for injection in [...]
Loading ...
